Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.44 USD | -1.26% | -8.95% | -5.96% |
May. 02 | Transcript : Vir Biotechnology, Inc., Q1 2024 Earnings Call, May 02, 2024 | |
May. 02 | Earnings Flash (VIR) VIR BIOTECHNOLOGY Reports Q1 Revenue $56.4M, vs. Street Est of $11.7M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.96% | 1.3B | |
+18.00% | 47.02B | |
+48.77% | 41.86B | |
+1.13% | 41.76B | |
-4.27% | 28.8B | |
+11.32% | 26.05B | |
-21.28% | 19.15B | |
+4.76% | 12.55B | |
+27.41% | 12.34B | |
-3.73% | 11.82B |
- Stock Market
- Equities
- VIR Stock
- News Vir Biotechnology, Inc.
- Vir Biotechnology : JPMorgan Downgrades Vir Biotechnology to Underweight From Neutral; Price Target is $30